White House Nixes Updated FDA Guidelines On Vaccines

WASHINGTON (AP) – The White House has blocked new Food and Drug Administration guidelines on bringing potential vaccines for COVID-19 to market that would almost certainly have prevented their approval before the Nov. 3 election. At issue was the FDA’s planned requirement that participants in mass clinical trials for vaccines be followed for two months to ensure there are no side effects and that the vaccines provide lasting protection. Despite the move by the White House, FDA officials say companies are aware of the standards and are expected to comply with them.